These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Treatment of anaerobic infections: an overview. Finegold SM Scand J Infect Dis Suppl; 1985; 46():89-95. PubMed ID: 3865355 [TBL] [Abstract][Full Text] [Related]
3. Current antimicrobial therapy of anaerobic infections. Sanders CV; Aldridge KE Eur J Clin Microbiol Infect Dis; 1992 Nov; 11(11):999-1011. PubMed ID: 1295770 [TBL] [Abstract][Full Text] [Related]
4. Role of newer antimicrobial agents in the treatment of mixed aerobic and anaerobic infections. Karam GH; Sanders CV; Aldridge KE Surg Gynecol Obstet; 1991; 172 Suppl():57-64. PubMed ID: 2024228 [TBL] [Abstract][Full Text] [Related]
5. The occurrence, virulence, and antimicrobial resistance of anaerobes in polymicrobial infections. Aldridge KE Am J Surg; 1995 May; 169(5A Suppl):2S-7S. PubMed ID: 7755163 [TBL] [Abstract][Full Text] [Related]
6. Anaerobes in polymicrobial surgical infections: incidence, pathogenicity, and antimicrobial resistance. Aldridge KE Eur J Surg Suppl; 1994; (573):31-7. PubMed ID: 7524793 [TBL] [Abstract][Full Text] [Related]
9. Anaerobic bacteria isolated from foot infections in diabetic patients: in vitro susceptibility to nine antibiotics. Ginunas VJ; Canawati HN; Sapico FL Clin Ther; 1984; 6(4):457-60. PubMed ID: 6467279 [TBL] [Abstract][Full Text] [Related]
10. [Infections by anaerobes in children: frequency of isolation and antimicrobial resistance]. Leaños B; Guiscafré H; Guerra R; Sandoval M; Rubí S; Trejo JA; Zúñiga V Bol Med Hosp Infant Mex; 1989 Jul; 46(7):455-62. PubMed ID: 2788434 [TBL] [Abstract][Full Text] [Related]
11. Anaerobic infections in small animals. Boothe DM Probl Vet Med; 1990 Jun; 2(2):330-47. PubMed ID: 2134596 [TBL] [Abstract][Full Text] [Related]
12. Susceptibility of anaerobic bacteria in Auckland: 1991-1996. Shore KP; Pottumarthy S; Morris AJ N Z Med J; 1999 Nov; 112(1099):424-6. PubMed ID: 10678225 [TBL] [Abstract][Full Text] [Related]
13. Surveillance of susceptibility patterns in 1297 European and US anaerobic and capnophilic isolates to co-amoxiclav and five other antimicrobial agents. Koeth LM; Good CE; Appelbaum PC; Goldstein EJ; Rodloff AC; Claros M; Dubreuil LJ J Antimicrob Chemother; 2004 Jun; 53(6):1039-44. PubMed ID: 15128729 [TBL] [Abstract][Full Text] [Related]
14. Antimicrobial resistance and resistance transfer in anaerobic. A review. Tally FP; Malamy MH Scand J Gastroenterol Suppl; 1984; 91():21-30. PubMed ID: 6377471 [TBL] [Abstract][Full Text] [Related]
15. Susceptibility of anaerobic bacteria to five antimicrobial agents and demonstration of resistance of Bacteroides fragilis to clindamycin. Sofianou D; Douboyas J; Papapanagiotou J; Paradelis AG Methods Find Exp Clin Pharmacol; 1982; 4(3):173-7. PubMed ID: 7121128 [TBL] [Abstract][Full Text] [Related]
17. Antimicrobial susceptibility of anaerobic bacteria in New Zealand: 1999-2003. Roberts SA; Shore KP; Paviour SD; Holland D; Morris AJ J Antimicrob Chemother; 2006 May; 57(5):992-8. PubMed ID: 16507560 [TBL] [Abstract][Full Text] [Related]
18. Antimicrobial susceptibility of anaerobic and aerobic bacteria isolated from patients with mixed infections in Nicaragua. Cáceres M; Carrera E; Palma A; Berrios G; Weintraub A; Nord CE Rev Esp Quimioter; 1999 Dec; 12(4):332-9. PubMed ID: 10855012 [TBL] [Abstract][Full Text] [Related]
19. Therapy for infections due to anaerobic bacteria: an overview. Finegold SM J Infect Dis; 1977 Mar; 135 Suppl():S25-9. PubMed ID: 321708 [TBL] [Abstract][Full Text] [Related]